510(k) K240670— DRI Ecstasy Plus Assay

Substantially Equivalent

Microgenics Corporation

Clearance details

Applicant: Microgenics Corporation
Product code: Code DKZ
Advisory panel: Clinical Toxicology
Date received: 2024-03-11
Decision date: 2024-10-30
Decision: Substantially Equivalent
Clearance type: Special
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.